131
Breast cancer tissue array (Her-2���3+/2+/1+/0), including pathology grade, TNM, clinical stage and IHC marker (ER, PR, Her-2 and Ki67), 4 cases/8 cores, replacing BR082d
(No reviews yet)
Write a Review
- SKU:
- 131-BR082e-GEN
- Availability:
- IN STOCK
Description
Breast cancer tissue array (Her-2���3+/2+/1+/0), including pathology grade, TNM, clinical stage and IHC marker (ER, PR, Her-2 and Ki67), 4 cases/8 cores, replacing BR082d
Related Products
Breast cancer tissue array, including pathology grade, TNM, clinical stage and IHC marker (Her-2/PR/ER), 4 cases/8 cores, replacing BR082b
131
NULL206.00
Breast cancer tissue array, including pathology grade, TNM, clinical stage and IHC marker (Her-2/PR/ER), 4 cases/8 cores, replacing BR082b
131-BR082c-GEN
Breast cancer with matched cancer adjacent breast tissue array, including pathology grade, TNM, clinical stage and IHC markers (ER, PR, Her-2 and Ki67), 40 cases/80 cores, replacing BR804a
131
NULL399.00
Breast cancer with matched cancer adjacent breast tissue array, including pathology grade, TNM, clinical stage and IHC markers (ER, PR, Her-2 and Ki67), 40 cases/80 cores, replacing BR804a
131-BR804b-GEN
Breast cancer tissue array, including TNM and pathology grade, with IHC results of Her-2\ER\PR\Ki67, 75 cases/ 150 cores, replacing BR1503f
131
NULL399.00
Breast cancer tissue array, including TNM and pathology grade, with IHC results of Her-2\ER\PR\Ki67, 75 cases/ 150 cores, replacing BR1503f
131-BR1503g-GEN
Breast cancer tissue array, including TNM and pathology grade, with IHC results of Her-2\ER\PR\Ki67, 75 cases/ 150 cores, replacing BR1503e
131
NULL399.00
Breast cancer tissue array, including TNM and pathology grade, with IHC results of Her-2\ER\PR\Ki67, 75 cases/ 150 cores, replacing BR1503e
131-BR1503f-GEN
Breast cancer tissue array, including TNM, clinical stage and pathology grade, with IHC results of Her-2, ER, PR, 75 cases/ 150 cores, replaced by BR1503e
131
NULL399.00
Breast cancer tissue array, including TNM, clinical stage and pathology grade, with IHC results of Her-2, ER, PR, 75 cases/ 150 cores, replaced by BR1503e
131-BR1503d-GEN
Breast cancer tissue array with adjacent breast tissue as control,, including pathology grade, TNM, clinical stage and IHC markers (ER, PR and Her-2), 110 cases/ 110 cores, replacing BC081116a
131
NULL399.00
Breast cancer tissue array with adjacent breast tissue as control,, including pathology grade, TNM, clinical stage and IHC markers (ER, PR and Her-2), 110 cases/ 110 cores, replacing BC081116a
131-BC081116b-GEN
Breast cancer with ER Immunohistochemistry control tissue array, including pathology grade, TNM, clinical stage and IHC results of ER/PR/Her-2/Ki67, 10 cases/10 cores, replacing PM2-ER
131
NULL206.00
Breast cancer with ER Immunohistochemistry control tissue array, including pathology grade, TNM, clinical stage and IHC results of ER/PR/Her-2/Ki67, 10 cases/10 cores, replacing PM2-ER
131-PM2a-ER-GEN
Breast cancer with adjacent normal breast tissue array, including pathology grade, TNM���clinical stage and IHC marker (ER, PR and Her-2), 189 cases/192 cores, replacing BR1921b
131
NULL602.00
Breast cancer with adjacent normal breast tissue array, including pathology grade, TNM���clinical stage and IHC marker (ER, PR and Her-2), 189 cases/192 cores, replacing BR1921b
131-BR1921c-GEN
Breast cancer array with adjacent normal breast tissue, including pathology grade, TNM, clinical stage and IHC markers (ER, PR and Her-2), 110 cases/110 cores, replacing BC081120c
131
NULL399.00
Breast cancer array with adjacent normal breast tissue, including pathology grade, TNM, clinical stage and IHC markers (ER, PR and Her-2), 110 cases/110 cores, replacing BC081120c
131-BC081120d-GEN